Business Consulting International

Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.

Retrieved on: 
Wednesday, November 30, 2022
Cardiology, Biotechnology, Practice Management, Technology, Managed Care, Health, Pharmaceutical, Health Technology, Medical Devices, Telecommunications, Telemedicine, Virtual Medicine, Pillar, Marketing, Diuresis, Heart, Urination, Science, Pharmacy, Business Consulting International, Acceleration, Edema, Risk, Hospital, Physician, MBA, Patient, Heart failure, Strategic planning, Kidney, Drug Quality and Security Act, Health policy, Medicine, MD, Swelling, Health, Security (finance), American University of Integrative Sciences, Quality of life, Consultant, CCI, Abdomen, FDA, Clinical, Pharmaceutical industry, Healthcare

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International LLC (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Agreement (the Agreement) with Sarfez Pharmaceuticals, Inc. (Sarfez), a pharmaceutical research and development company with an FDA-approved edema treatment for patients with heart failure and renal disease.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International LLC (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Agreement (the Agreement) with Sarfez Pharmaceuticals, Inc. (Sarfez), a pharmaceutical research and development company with an FDA-approved edema treatment for patients with heart failure and renal disease.
  • CCI, a Novo wholly owned subsidiary, was established in 2006 in Michigan as a local hospital consulting firm.
  • Headquartered in Boca Raton, Florida, CCI leverages 30+ years of industry experience and its expert consultants worldwide to support clients.
  • Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient-first platforms.

Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.

Retrieved on: 
Tuesday, November 8, 2022
Technology, Nursing, Hospitals, Health Technology, Telemedicine, Virtual Medicine, Software, Practice Management, Managed Care, Health, Pillar, Strategic planning, NASDAQ, MBA, Health information management, Hospital, Technology, Length of stay, Uniloc USA, Inc. v. Microsoft Corp., U.S. Securities and Exchange Commission, Industry, Business Consulting International, Patient, Company, MD, Home, Population, Securities Exchange Act of 1934, Consultant, Drug Quality and Security Act, Nursing, Insurance, Ecosystem, Health policy, Telehealth, Securities Act of 1933, CPT, Health, Science, American University of Integrative Sciences, CCI, Efficiency, Acceleration, Solution, DRG, ICD, Security (finance), Dr. Jeyasekharan Hospital & Nursing Home, Clinical, Fine chemical, Pharmaceutical industry, Medicine, Healthcare

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Sales and Consulting Agreement (the Agreement), which includes revenue-sharing potential, with TiaTech USA Inc. (TiaTech), a leader in state-of-the-art health tech solutions.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Sales and Consulting Agreement (the Agreement), which includes revenue-sharing potential, with TiaTech USA Inc. (TiaTech), a leader in state-of-the-art health tech solutions.
  • Dr. Joseph M. Chalil, MD, MBA, FACHE, Chief Medical Officer of Novo, stated, TiaTechs ecosystem is the wave of the future for healthcare interconnectivity globally.
  • The TiaTech ecosystem is ideal for rural hospitals, nursing homes, assisted living, and homes where physician and specialty oversight is lacking.
  • Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient-first platforms.

Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions

Retrieved on: 
Tuesday, October 25, 2022
Software, Mobile, Wireless, Data Management, IOT (Internet of Things), Consumer, Mental Health, Apps, Applications, Technology, Artificial Intelligence, Health Technology, Seniors, Health, Pillar, Orangi Pilot Project, United States Secretary of Labor, Science, Machine learning, Strategic planning, NASDAQ, Securities Act of 1933, Business Consulting International, App Store (iOS/iPadOS), Vital signs, Solution, Communication, Touchless knockout, Technology, Population, Acceleration, DSP, American University of Integrative Sciences, MBA, Clinical, Falls, Roc, Senior, Company, Industry, Consultant, Health, Health policy, Security (finance), IOT, Digital signal processor, Collection, MCU, Securities Exchange Act of 1934, U.S. Securities and Exchange Commission, CCI, Algorithm, Tranquillity, Drug Quality and Security Act, TKS, Patient, Digital signal, TLS, MD, Safety, Radar, Pharmaceutical industry, Medical imaging, Healthcare

To date, CCIs successful collaboration with Tranquility has already resulted in the launch of two separate pilot projects with a U.S.-based Senior Housing Network and a U.S.

Key Points: 
  • To date, CCIs successful collaboration with Tranquility has already resulted in the launch of two separate pilot projects with a U.S.-based Senior Housing Network and a U.S.
  • These components include an integrated Digital Signal Processor (DSP) and an MCU for complex signal and image processing.
  • Headquartered in Boca Raton, Florida, we leverage 30+ years of industry experience and our expert consultants worldwide to support our clients.
  • Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient first platforms.

Softhread Announces Collaboration with Clinical Consultants International (CCI), a Wholly-Owned Subsidiary of Novo Integrated Sciences Inc.

Retrieved on: 
Monday, October 24, 2022
Health policy, IOT, Strategic planning, Health, Privacy, MBA, Confidentiality, Data management, ROI, Solution, MD, Industry, AI, Information technology, CEO, Ecosystem, Business Consulting International, CCI, CII, Consultant, Medical device, Cryptocurrency

BALTIMORE, Oct. 24, 2022 /PRNewswire/ -- Softhread Inc. is pleased to announce an agreement with Clinical Consultants International (CCI), a wholly-owned subsidiary of Novo Integrated Sciences Inc., to offer a zero trust cybersecurity solution for smart and interconnected healthcare services consolidating its entrance into the rapidly evolving Health Care 4.0 ecosystem for health care delivery.

Key Points: 
  • Dr. Joseph M. Chalil, MD, MBA, FACHE, Chief Medical Officer of Novo, stated, "We are pleased to partner with Softhread as it rapidly evolves into the Health Care 4.0 ecosystem.
  • Softhread's proven cybersecurity, AI and blockchain engineering powers zero-trust solutions, enhancing any existing cyber-defense systems.
  • Together, we are also exploring the integration of Softhread's technology into Novo Connect, Novo's proprietary mobile application, to further enhance a secure and reliable consumer experience."
  • Headquartered in Boca Raton, Florida, we leverage 30+ years of industry experience and our expert consultants worldwide to support our clients.

Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread

Retrieved on: 
Wednesday, October 12, 2022
Medical Supplies, Biotechnology, Technology, Health, Pharmaceutical, Infectious Diseases, Artificial Intelligence, Networks, Internet, Mobile, Wireless, COVID-19, Pillar, Health, Health policy, U.S. Securities and Exchange Commission, Nurses station, Drug Quality and Security Act, Technology, Population, Paola Lattus, Pharmacy, Science, Acceleration, Laboratory, Policy, Strategic planning, PHI, NASDAQ, Patient, Privacy, American University of Integrative Sciences, Agreement, MBA, Security (finance), Confidentiality, Securities Act of 1933, Clinical, Artificial intelligence, Data management, ROI, Solution, Company, MD, Industry, AI, Information technology, Board, Blockchain, Internet, Consultant, Securities Exchange Act of 1934, Business Consulting International, CCI, Cryptocurrency, Medical device, Hospital, Healthcare, Pharmaceutical industry

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement (the Agreement), which includes revenue-sharing potential, with Softhread, Inc., an information technology company which offers a proprietary, patent-pending blockchain and AI-enabled platform that preserves confidentiality and optimizes network security, while enhancing operational efficiency.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the Company or Novo), and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement (the Agreement), which includes revenue-sharing potential, with Softhread, Inc., an information technology company which offers a proprietary, patent-pending blockchain and AI-enabled platform that preserves confidentiality and optimizes network security, while enhancing operational efficiency.
  • Together, we are also exploring the integration of Softhreads technology into Novo Connect, Novos proprietary mobile application, to further enhance a secure and reliable consumer experience.
  • Softhread brings a modular blockchain architecture for the veracity and security of information exchanges among all IoT-connected Health Care 4.0 stakeholders.
  • Innovation through science combined with the integration of sophisticated, secure technology assures Novo Integrated Sciences of continued cutting-edge advancement in patient first platforms.

Capital Consulting International (CCi) Acquires Hargreaves Jones

Retrieved on: 
Thursday, June 23, 2022
Commercial Building & Real Estate, Construction & Property, Insurance, Consulting, Other Energy, Oil, Gas, Professional Services, Energy, Nuclear, Residential Building & Real Estate, Capital, Partnership, United Kingdom, Architecture, Insurance, CCI, Built environment, Acquisition, Government, Business Consulting International, Engineering, Risk management

Capital Consulting International (CCi), A Rimkus Company, today announced the acquisition of Manchester-based Hargreaves Jones , a commercial and project management consultancy serving the oil, gas, nuclear, utilities, pharmaceutical, commercial, and fast-moving consumer goods sectors.

Key Points: 
  • Capital Consulting International (CCi), A Rimkus Company, today announced the acquisition of Manchester-based Hargreaves Jones , a commercial and project management consultancy serving the oil, gas, nuclear, utilities, pharmaceutical, commercial, and fast-moving consumer goods sectors.
  • Together, we are poised for success today and well into the future, said Dave Webster, Group Managing Director, Capital Consulting International, A Rimkus Company.
  • At Hargreaves Jones, we pride ourselves on deep industry expertise and top-level approach to client service.
  • We look forward to embarking on this exciting new chapter, said Peter Hargreaves, Managing Director, Hargreaves Jones.

AVASK Partners With OFX To Offer A Multi-currency Account Solution And Global Money Transfer Services To Their E-commerce Clients

Retrieved on: 
Tuesday, October 19, 2021
ASX, SGD, VAT, Technology, Australian Securities Exchange, OFX, Consultant, Goal, Business Consulting International, SAN, CAD, Foreign currency account, NMLS, USD, Time, Dream, GBP, City, AUD, Partnership, Heart, Solution, HKD, Financial services, Cryptocurrency, Online shopping

OFX will offer Global Currency Accounts, currency risk management solutions and bank-beating rates on global money transfers to AVASK's portfolio of e-commerce clients.

Key Points: 
  • OFX will offer Global Currency Accounts, currency risk management solutions and bank-beating rates on global money transfers to AVASK's portfolio of e-commerce clients.
  • OFX and AVASK place supporting clients' dreams of global expansion at the heart of their operations.
  • Both OFX and AVASK place supporting clients' dreams of global expansion at the heart of their operations.
  • In offering our Global Currency Account as a solution to AVASK clients, we can enable them to move money globally at game changing rates, helping them scale with ease."